Novel AI tools tackle soft tissue sarcomas, identify new treatment strategies

byStanford University Medical CenterA machine-learning framework for large-scale identification and validation of sarcoma cell states and ecosystems. Credit:Nature Cancer(2024). DOI:

Updated on: March 30,2024 0

Novel AI tools tackle soft tissue sarcomas, identify new treatment strategies

byStanford University Medical CenterA machine-learning framework for large-scale identification and validation of sarcoma cell states and ecosystems. Credit:Nature Cancer(2024). DOI:

Updated on:March 30,2024 0

COVID-19 pandemic could have led to 20,000 prostate cancer diagnosis being missed

byUniversity of SurreyObserved and predicted trends over time from January 2015 to July 2023 showing rates per 100 000 registered adult men (A) prostate cancer incidence, (B) prevalence, and (C)

Updated on: March 30,2024 0

COVID-19 pandemic could have led to 20,000 prostate cancer diagnosis being missed

byUniversity of SurreyObserved and predicted trends over time from January 2015 to July 2023 showing rates per 100 000 registered adult men (A) prostate cancer incidence, (B) prevalence, and (C)

Updated on:March 30,2024 0

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on: March 30,2024 0

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on:March 30,2024 0

Study finds adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

byUniversity of California, Los AngelesCredit: Miguel Á. Padriñán from PexelsA new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amoun

Updated on: March 30,2024 0

Study finds adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

byUniversity of California, Los AngelesCredit: Miguel Á. Padriñán from PexelsA new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amoun

Updated on:March 30,2024 0

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on: March 30,2024 0

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on:March 30,2024 0

Subtyping of breast cancer cell lines reveals insights into cancer-relevant genes

by Manuela Schüngel, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbHWaterfall plot depicting recurrent non-synonymous mutations in BC cell lines. Mutations were calle

Updated on: March 30,2024 0

Subtyping of breast cancer cell lines reveals insights into cancer-relevant genes

by Manuela Schüngel, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbHWaterfall plot depicting recurrent non-synonymous mutations in BC cell lines. Mutations were calle

Updated on:March 30,2024 0

Study reveals inequities in access to CAR T cell therapy

by Meagan Raeke,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainPatients being treated for B-cell non-Hodgkin's Lymphoma (NHL) who are part of minority

Updated on: March 30,2024 0

Study reveals inequities in access to CAR T cell therapy

by Meagan Raeke,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainPatients being treated for B-cell non-Hodgkin's Lymphoma (NHL) who are part of minority

Updated on:March 30,2024 0

Some cancer patients can find it hard to tell family and friends

by Kenya HunterThis combination of 2023 photos shows Kate, Princess of Wales, left, and U.S. Secretary of Defense Lloyd Austin. For some cancer patients, sharing the news can be a difficult decision.

Updated on: March 30,2024 0

Some cancer patients can find it hard to tell family and friends

by Kenya HunterThis combination of 2023 photos shows Kate, Princess of Wales, left, and U.S. Secretary of Defense Lloyd Austin. For some cancer patients, sharing the news can be a difficult decision.

Updated on:March 30,2024 0

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on: March 30,2024 0

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on:March 30,2024 0

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on: March 30,2024 0

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on:March 30,2024 0

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on: March 30,2024 0

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on:March 30,2024 0

Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments

by Institute for Bioengineering of CataloniaGraphical abstract. Credit:Cancers(2024). DOI: 10.3390/cancers16051060Neuroblastoma, one of the most common childhood cancers, is classified as

Updated on: March 30,2024 0

Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments

by Institute for Bioengineering of CataloniaGraphical abstract. Credit:Cancers(2024). DOI: 10.3390/cancers16051060Neuroblastoma, one of the most common childhood cancers, is classified as

Updated on:March 30,2024 0